Background In vitro eosinophil (EOS) adhesion to recombinant human (rh)-vas
cular cell adhesion molecule (VCAM)-1 stimulates superoxide anion (O-2(-))
generation and enhances formyl-methionyl-leucyl phenylalanine (FMLP)-activa
ted O-2(-) generation. Therefore, EOS adhesion via VLA-4 to VCAM-1 expresse
d on endothelium may be instrumental in the selective recruitment and funct
ion of EOS in airway inflammation.
Objective We hypothesized that EOS interaction with endothelial cells expre
ssing VCAM-1 will undergo an enhancement in inflammatory function.
Methods To determine this possibility, human umbilical vein endothelial cel
ls (HUVEC) were stimulated with either a combination of interleukin (IL)-4
and tumour necrosis factor (TNF)-alpha (100pM) or medium alone for 24h; the
expression of adhesion proteins on HUVEC and their effect on EOS O-2(-) ge
neration was subsequently determined.
Results As determined by both enzyme-linked immunosorbent assay and flow cy
tometry, IL-4 and TNF alpha acted synergistically to induce VCAM-1 expressi
on on HUVEC. Treating HUVEC with IL-4/TNF alpha also increased EOS adhesion
and primed subsequent FMLP (0.1 mu M) activated EOS O-2(-) generation. Alt
hough EOS adhesion was partially inhibited by both anti alpha(4) and anti b
eta(2) monoclonal antibodies (MoAbs), O-2(-) generation was completely inhi
bited by either anti alpha(4) integrin MoAb (HP1/2) or anti-VCAM MoAb (BBIG
-V1). Furthermore, enhanced O-2(-) generation, but not adhesion, associated
with IL-4 + TNF alpha-treatment of HUVEC was inhibited when EOS were treat
ed with the platelet activating factor (PAF)-antagonist WEB 2086 (20 mu M),
thus suggesting an involvement of PAF in priming EOS. However, paraformald
ehyde fixation of IL-4/TFN-alpha treated HUVEC did not significantly alter
EOS function,
Conclusions These results suggest EOS adhesion to endothelial cells via an
VLA-4/VCAM-1 interaction may be important in the development of the functio
n of this cell, Furthermore, our results suggest that modulation of EOS fun
ction involves two priming factors: EOS adhesion to HUVEC expressing VCAM-1
and PAF.